The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Molecular Imaging Agents-Global Market Insights and Sales Trends 2024
Synopsis
Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
The global Molecular Imaging Agents market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Imaging Agents in various end use industries. The expanding demands from the Oncology, Cardiology, Gastrointestinal Disorders and Neurology Disorders, are propelling Molecular Imaging Agents market. Small Molecules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Peptides segment is estimated at % CAGR for the next seven-year period.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Imaging Agents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Imaging Agents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Imaging Agents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Imaging Agents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Imaging Agents covered in this report include General Electric, Bracco Diagnostic, Eisai and Guerbet, etc.
The global Molecular Imaging Agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
General Electric
Bracco Diagnostic
Eisai
Guerbet
Global Molecular Imaging Agents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Imaging Agents market, Segment by Type:
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Global Molecular Imaging Agents market, by Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Molecular Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
The global Molecular Imaging Agents market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Imaging Agents in various end use industries. The expanding demands from the Oncology, Cardiology, Gastrointestinal Disorders and Neurology Disorders, are propelling Molecular Imaging Agents market. Small Molecules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Peptides segment is estimated at % CAGR for the next seven-year period.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Imaging Agents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Imaging Agents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Imaging Agents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Imaging Agents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Imaging Agents covered in this report include General Electric, Bracco Diagnostic, Eisai and Guerbet, etc.
The global Molecular Imaging Agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
General Electric
Bracco Diagnostic
Eisai
Guerbet
Global Molecular Imaging Agents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Imaging Agents market, Segment by Type:
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Global Molecular Imaging Agents market, by Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Molecular Imaging Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Molecular Imaging Agents Market Overview
1.1 Molecular Imaging Agents Product Overview
1.2 Molecular Imaging Agents Market Segment by Type
1.2.1 Small Molecules
1.2.2 Peptides
1.2.3 Engineered Protein Fragments
1.2.4 Aptamers
1.2.5 Nanoparticles
1.2.6 Others
1.3 Global Molecular Imaging Agents Market Size by Type
1.3.1 Global Molecular Imaging Agents Market Size Overview by Type (2018-2029)
1.3.2 Global Molecular Imaging Agents Historic Market Size Review by Type (2018-2023)
1.3.3 Global Molecular Imaging Agents Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Molecular Imaging Agents Sales Breakdown by Type (2018-2023)
1.4.2 Europe Molecular Imaging Agents Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Molecular Imaging Agents Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Molecular Imaging Agents Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Molecular Imaging Agents Sales Breakdown by Type (2018-2023)
2 Global Molecular Imaging Agents Market Competition by Company
2.1 Global Top Players by Molecular Imaging Agents Sales (2018-2023)
2.2 Global Top Players by Molecular Imaging Agents Revenue (2018-2023)
2.3 Global Top Players by Molecular Imaging Agents Price (2018-2023)
2.4 Global Top Manufacturers Molecular Imaging Agents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Molecular Imaging Agents Market Competitive Situation and Trends
2.5.1 Molecular Imaging Agents Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Molecular Imaging Agents Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Imaging Agents as of 2022)
2.7 Date of Key Manufacturers Enter into Molecular Imaging Agents Market
2.8 Key Manufacturers Molecular Imaging Agents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Molecular Imaging Agents Status and Outlook by Region
3.1 Global Molecular Imaging Agents Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Molecular Imaging Agents Historic Market Size by Region
3.2.1 Global Molecular Imaging Agents Sales in Volume by Region (2018-2023)
3.2.2 Global Molecular Imaging Agents Sales in Value by Region (2018-2023)
3.2.3 Global Molecular Imaging Agents Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Molecular Imaging Agents Forecasted Market Size by Region
3.3.1 Global Molecular Imaging Agents Sales in Volume by Region (2024-2029)
3.3.2 Global Molecular Imaging Agents Sales in Value by Region (2024-2029)
3.3.3 Global Molecular Imaging Agents Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Molecular Imaging Agents by Application
4.1 Molecular Imaging Agents Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Gastrointestinal Disorders
4.1.4 Neurology Disorders
4.1.5 Others
4.2 Global Molecular Imaging Agents Market Size by Application
4.2.1 Global Molecular Imaging Agents Market Size Overview by Application (2018-2029)
4.2.2 Global Molecular Imaging Agents Historic Market Size Review by Application (2018-2023)
4.2.3 Global Molecular Imaging Agents Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Molecular Imaging Agents Sales Breakdown by Application (2018-2023)
4.3.2 Europe Molecular Imaging Agents Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Molecular Imaging Agents Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Molecular Imaging Agents Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Molecular Imaging Agents Sales Breakdown by Application (2018-2023)
5 North America Molecular Imaging Agents by Country
5.1 North America Molecular Imaging Agents Historic Market Size by Country
5.1.1 North America Molecular Imaging Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Molecular Imaging Agents Sales in Volume by Country (2018-2023)
5.1.3 North America Molecular Imaging Agents Sales in Value by Country (2018-2023)
5.2 North America Molecular Imaging Agents Forecasted Market Size by Country
5.2.1 North America Molecular Imaging Agents Sales in Volume by Country (2024-2029)
5.2.2 North America Molecular Imaging Agents Sales in Value by Country (2024-2029)
6 Europe Molecular Imaging Agents by Country
6.1 Europe Molecular Imaging Agents Historic Market Size by Country
6.1.1 Europe Molecular Imaging Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Molecular Imaging Agents Sales in Volume by Country (2018-2023)
6.1.3 Europe Molecular Imaging Agents Sales in Value by Country (2018-2023)
6.2 Europe Molecular Imaging Agents Forecasted Market Size by Country
6.2.1 Europe Molecular Imaging Agents Sales in Volume by Country (2024-2029)
6.2.2 Europe Molecular Imaging Agents Sales in Value by Country (2024-2029)
7 Asia-Pacific Molecular Imaging Agents by Region
7.1 Asia-Pacific Molecular Imaging Agents Historic Market Size by Region
7.1.1 Asia-Pacific Molecular Imaging Agents Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Molecular Imaging Agents Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Molecular Imaging Agents Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Molecular Imaging Agents Forecasted Market Size by Region
7.2.1 Asia-Pacific Molecular Imaging Agents Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Molecular Imaging Agents Sales in Value by Region (2024-2029)
8 Latin America Molecular Imaging Agents by Country
8.1 Latin America Molecular Imaging Agents Historic Market Size by Country
8.1.1 Latin America Molecular Imaging Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Molecular Imaging Agents Sales in Volume by Country (2018-2023)
8.1.3 Latin America Molecular Imaging Agents Sales in Value by Country (2018-2023)
8.2 Latin America Molecular Imaging Agents Forecasted Market Size by Country
8.2.1 Latin America Molecular Imaging Agents Sales in Volume by Country (2024-2029)
8.2.2 Latin America Molecular Imaging Agents Sales in Value by Country (2024-2029)
9 Middle East and Africa Molecular Imaging Agents by Country
9.1 Middle East and Africa Molecular Imaging Agents Historic Market Size by Country
9.1.1 Middle East and Africa Molecular Imaging Agents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Molecular Imaging Agents Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Molecular Imaging Agents Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Molecular Imaging Agents Forecasted Market Size by Country
9.2.1 Middle East and Africa Molecular Imaging Agents Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Molecular Imaging Agents Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 General Electric
10.1.1 General Electric Company Information
10.1.2 General Electric Introduction and Business Overview
10.1.3 General Electric Molecular Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
10.1.4 General Electric Molecular Imaging Agents Products Offered
10.1.5 General Electric Recent Development
10.2 Bracco Diagnostic
10.2.1 Bracco Diagnostic Company Information
10.2.2 Bracco Diagnostic Introduction and Business Overview
10.2.3 Bracco Diagnostic Molecular Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bracco Diagnostic Molecular Imaging Agents Products Offered
10.2.5 Bracco Diagnostic Recent Development
10.3 Eisai
10.3.1 Eisai Company Information
10.3.2 Eisai Introduction and Business Overview
10.3.3 Eisai Molecular Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eisai Molecular Imaging Agents Products Offered
10.3.5 Eisai Recent Development
10.4 Guerbet
10.4.1 Guerbet Company Information
10.4.2 Guerbet Introduction and Business Overview
10.4.3 Guerbet Molecular Imaging Agents Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Guerbet Molecular Imaging Agents Products Offered
10.4.5 Guerbet Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Molecular Imaging Agents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Molecular Imaging Agents Industrial Chain Analysis
11.4 Molecular Imaging Agents Market Dynamics
11.4.1 Molecular Imaging Agents Industry Trends
11.4.2 Molecular Imaging Agents Market Drivers
11.4.3 Molecular Imaging Agents Market Challenges
11.4.4 Molecular Imaging Agents Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Molecular Imaging Agents Distributors
12.3 Molecular Imaging Agents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
